1. |
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006, 3(11): e442.
|
2. |
Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. Eur Respir J, 2015, 45(2): 310-313.
|
3. |
Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004, 170(4): 400-407.
|
4. |
Minov J, Stoleski S, Mijakoski D, et al. Exacerbations in COPD patients with bronchiectasis. Med Sci (Basel), 2017, 5(2): pii: E7.
|
5. |
Martinez-Garcia MA, de la Rosa Carrillo D, Soler-Cataluna JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2013, 187(8): 823-831.
|
6. |
Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax, 1992, 47(1): 25-29.
|
7. |
Ooi GC, Khong PL, Chan-Yeung M, et al. High-resolution CT quantification of bronchiectasis: clinical and functional correlation. Radiology, 2002, 225(3): 663-672.
|
8. |
Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004, 350(10): 1005-1012.
|
9. |
Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest, 2007, 132(3): 1565-1572.
|
10. |
GOLD. Global Strategy for the Diagnosis Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available at: https://goldcoped.org/, 2014.
|
11. |
Blasi F, Chalmers JD, Aliberti S. COPD and bronchiectasis: phenotype, endotype or co-morbidity?. COPD, 2014, 11(6): 603-604.
|
12. |
Smith IE, Jurriaans E, Diederich S, et al. Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax, 1996, 51(9): 914-918.
|
13. |
Demkow U, van Overveld FJ. Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment. Eur J Med Res, 2010, 15(Suppl 2): 27-35.
|
14. |
Gramegna A, Amati F, Terranova L, et al. Neutrophil elastase in bronchiectasis. Respir Res, 2017, 18: 211.
|
15. |
Churg A, Zhou S, Wright JL. Series "matrix metalloproteinases in lung health and disease": matrix metalloproteinases in COPD. Eur Respir J, 2012, 39(1): 197-209.
|
16. |
Pifferi M, Bush A, Caramella D, et al. Matrix metalloproteinases and airway remodeling and function in primary ciliary dyskinesia. Respir Med, 2017, 124: 49-56.
|
17. |
Bchir S, Nasr HB, Bouchet S, et al. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease. J Cell Mol Med, 2017, 21(7): 1280-1291.
|